Global injectable drug delivery market predicted to grow 12.8 percent
Increasing demand for convenient drug delivery, as well as an increase in diseases such as diabetes, has fuelled the global injectable drug delivery market.
List view / Grid view
Increasing demand for convenient drug delivery, as well as an increase in diseases such as diabetes, has fuelled the global injectable drug delivery market.
King Pharmaceuticals Limited and Alissa Healthcare Research Limited have admitted to sharing information to keep drug prices up.
The global alopecia treatment market is projected to exhibit a CAGR of 4.9 percent from 2018–2026.
According to a new report, pharma companies in India are increasingly entering the Chinese pharma industry through joint ventures.
The pharmaceutical processing and packaging equipment market is expected to witness a high increase during the forecast period (2019-2025).
New investment provides substantial new funding to fuel the next stage of Quotient’s growth.
The price of over 3400 drugs have been hiked in the first half of 2019, surpassing the number of hikes imposed during the same period last year.
Pharmaceutical company, Pfizer, has announced it has completed the acquisition of Therachon for $340 million.
AbbVie Inc. and Allergan plc have entered into a definitive transaction agreement under which AbbVie will acquire Allergan.
A pharmaceutical company and a local council have announced investments to improve paediatric medicines manufacturing.
DHL Supply Chain is investing millions of dollars to expand its pharmaceutical and medical device distribution network in the US.
The UK’s newest life sciences asset, Health Innovation Research Alliance Northern Ireland (HIRANI), has been launched at a BIO reception.
The global pharmaceutical intermediates market is likely to see year-on-year growth in 2019, by an estimated 3.6 percent rate.
New briefing documents provide policy recommendations to help the EU tackle high medicines prices brought about by market monopolies.
Member countries of WHO have agreed to support pricing transparency for medicines, vaccines and other health products.